A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.
Public ClinicalTrials.gov record NCT00002253. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the relapse rate in patients with AIDS-related diarrhea who were found to be "Responders" in a previous placebo-controlled, double-blind study of Sandostatin (Study #D203 - FDA 102A). The secondary objectives include: 1) To evaluate clinical efficacy and safety of open-label Sandostatin in patients who were "Non-Responders" in Study #D203 - FDA 102A; 2) To evaluate the efficacy and safety of Sandostatin during prolonged open-label treatment in "Responders" from Study #D03 - FDA 102A.
Study identification
- NCT ID
- NCT00002253
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| USC School of Medicine | Los Angeles | California | 90033 | — |
| UCSD Med Ctr | San Diego | California | 92103 | — |
| UCSF - San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| Kaiser Permanente Med Ctr | San Francisco | California | 94115 | — |
| San Mateo County Gen Hosp | San Mateo | California | 94403 | — |
| Med Service | Miami | Florida | 33125 | — |
| Emory Univ School of Medicine | Atlanta | Georgia | 30303 | — |
| Rush Presbyterian - Saint Luke's Med Ctr | Chicago | Illinois | 60612 | — |
| Maine Med Ctr Med Clinics | Portland | Maine | 04102 | — |
| Douglas Plesko | Boston | Massachusetts | 02115 | — |
| Boston City Hosp | Boston | Massachusetts | 02118 | — |
| Henry Ford Hosp | Detroit | Michigan | 48202 | — |
| Univ of Missouri at Kansas City School of Medicine | Kansas City | Missouri | 64108 | — |
| Mount Sinai Med Ctr | New York | New York | 10029 | — |
| SUNY Stony Brook / Health Sciences Ctr | Stony Brook | New York | 117948121 | — |
| Portland Veterans Adm Med Ctr / Rsch & Education Grp | Portland | Oregon | 97210 | — |
| Buckley Braffman Stern Med Associates | Philadelphia | Pennsylvania | 19107 | — |
| Miriam Hosp / Family Healthcare Ctr at SSTAR | Providence | Rhode Island | 02906 | — |
| Univ TX Galveston Med Branch | Galveston | Texas | 77550 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Infectious Disease Physicians Inc | Annandale | Virginia | 22203 | — |
| Univ of Wisconsin School of Medicine | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Diarrhea trials
Other public records listing Diarrhea. Sorted by last update posted; newest first. Not a recommendation.
- NCT07781488: A Clinical Trial to Evaluate the Effects of a Fibre Supplement on Microbiome and Gut Health Active, not recruiting
- NCT07545759: A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) Recruiting
- NCT05776914: Fecal Microbiota Transplantation for IBS Recruiting
- NCT07230821: Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes Active, not recruiting
- NCT04038619: Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients Recruiting
- NCT07285785: Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002253, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002253 live on ClinicalTrials.gov.